학술논문

Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study
Document Type
Article
Source
In: Clinical Lymphoma, Myeloma and Leukemia. (Clinical Lymphoma, Myeloma and Leukemia, January 2024, 24(1):55-63)
Subject
Language
English
ISSN
21522669
21522650